A Complete Guide to Specialty Generics

The Specialty Generics Market is estimated to accelerate growth in the forecast period owing to driving factors such as the introduction of cost-effective drugs for the treatment of multiple sclerosis, cancer, and other infectious diseases, rise in the number of an off-patent specialty drug, early patent expirations are expected to boost the entry of new generics.

Grab PDF to Know More: - https://www.theinsightpartners.com/brochure/TIPRE00021203?utm_source=OpenPR&utm_medium=10209

Specialty generics are generic versions of specialty drugs once they get off-patent. Specialty generics are low-cost oral or injectable medications used to treat complex chronic conditions such as cancer, HIV, Hepatitis, multiple sclerosis. They are often biologics (derived from living cells) injectable or infused. According to U.S. FDA, generic drugs cost 80% to 85% lower as compared to branded drugs as they don't require costly development and marketing costs.

Formulation type (oral, parenteral, topical, others)

Therapeutic Application(oncology, inflammatory conditions, multiple sclerosis, hepatitis C,)

The report also includes the profiles of key players in Specialty Generics Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

Top Key Players:-

Valeant Pharmaceuticals International, Inc.,

Novartis

Pfizer Inc.,

Turing Pharmaceuticals,

Teva Pharmaceutical Ltd.,

Mylan N.V.,

Akorn, Inc.,

Mallinckrodt

Lupin Pharmaceuticals

Sandoz

Contact US
Contact Person : Ankit Mathur
Phone : +1-646-491-9876
E-mail : sales@theinsightpartners.com

About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

This release was published on openPR.